1. Home
  2. NBTX vs WHF Comparison

NBTX vs WHF Comparison

Compare NBTX & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • WHF
  • Stock Information
  • Founded
  • NBTX 2003
  • WHF 2011
  • Country
  • NBTX France
  • WHF United States
  • Employees
  • NBTX N/A
  • WHF N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • WHF Finance Companies
  • Sector
  • NBTX Health Care
  • WHF Finance
  • Exchange
  • NBTX Nasdaq
  • WHF Nasdaq
  • Market Cap
  • NBTX 211.9M
  • WHF 207.1M
  • IPO Year
  • NBTX 2020
  • WHF 2012
  • Fundamental
  • Price
  • NBTX $9.70
  • WHF $8.72
  • Analyst Decision
  • NBTX Strong Buy
  • WHF Hold
  • Analyst Count
  • NBTX 1
  • WHF 4
  • Target Price
  • NBTX $8.00
  • WHF $10.00
  • AVG Volume (30 Days)
  • NBTX 15.1K
  • WHF 60.5K
  • Earning Date
  • NBTX 09-18-2025
  • WHF 11-06-2025
  • Dividend Yield
  • NBTX N/A
  • WHF 20.47%
  • EPS Growth
  • NBTX N/A
  • WHF N/A
  • EPS
  • NBTX N/A
  • WHF 0.15
  • Revenue
  • NBTX N/A
  • WHF $81,499,000.00
  • Revenue This Year
  • NBTX N/A
  • WHF N/A
  • Revenue Next Year
  • NBTX $74.67
  • WHF N/A
  • P/E Ratio
  • NBTX N/A
  • WHF $56.98
  • Revenue Growth
  • NBTX N/A
  • WHF N/A
  • 52 Week Low
  • NBTX $2.76
  • WHF $8.36
  • 52 Week High
  • NBTX $10.59
  • WHF $12.42
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 62.98
  • WHF 54.98
  • Support Level
  • NBTX $8.03
  • WHF $8.65
  • Resistance Level
  • NBTX $9.14
  • WHF $8.78
  • Average True Range (ATR)
  • NBTX 0.56
  • WHF 0.08
  • MACD
  • NBTX -0.02
  • WHF 0.03
  • Stochastic Oscillator
  • NBTX 68.67
  • WHF 65.00

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.

Share on Social Networks: